These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11855877)
1. Survival among U.S. women with invasive epithelial ovarian cancer. McGuire V; Jesser CA; Whittemore AS Gynecol Oncol; 2002 Mar; 84(3):399-403. PubMed ID: 11855877 [TBL] [Abstract][Full Text] [Related]
2. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777 [TBL] [Abstract][Full Text] [Related]
3. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Li CI; Malone KE; Daling JR Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106 [TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma. O'Malley CD; Prehn AW; Shema SJ; Glaser SL Cancer; 2002 Jun; 94(11):2836-43. PubMed ID: 12115370 [TBL] [Abstract][Full Text] [Related]
5. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Chan JK; Munro EG; Cheung MK; Husain A; Teng NN; Berek JS; Osann K Obstet Gynecol; 2007 Jan; 109(1):12-9. PubMed ID: 17197582 [TBL] [Abstract][Full Text] [Related]
6. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Wu X; Matanoski G; Chen VW; Saraiya M; Coughlin SS; King JB; Tao XG Cancer; 2008 Nov; 113(10 Suppl):2873-82. PubMed ID: 18980291 [TBL] [Abstract][Full Text] [Related]
7. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691 [TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249 [TBL] [Abstract][Full Text] [Related]
9. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Jemal A; Clegg LX; Ward E; Ries LA; Wu X; Jamison PM; Wingo PA; Howe HL; Anderson RN; Edwards BK Cancer; 2004 Jul; 101(1):3-27. PubMed ID: 15221985 [TBL] [Abstract][Full Text] [Related]
10. Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT). Barnholtz-Sloan JS; Morris R; Malone JM; Munkarah AR Gynecol Oncol; 2004 May; 93(2):506-12. PubMed ID: 15099970 [TBL] [Abstract][Full Text] [Related]
11. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study. O'Malley CD; Le GM; Glaser SL; Shema SJ; West DW Cancer; 2003 Mar; 97(5):1303-11. PubMed ID: 12599239 [TBL] [Abstract][Full Text] [Related]
12. Cancer of the uterine corpus among Hispanic women living in the United States: patterns of staging, diagnosis, and primary treatment. Díaz-Montes TP; Alberg A; Zahurak ML; Trimble EL; Bristow RE Gynecol Oncol; 2005 Mar; 96(3):753-9. PubMed ID: 15721422 [TBL] [Abstract][Full Text] [Related]
13. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Choi M; Fuller CD; Thomas CR; Wang SJ Gynecol Oncol; 2008 May; 109(2):203-9. PubMed ID: 18329082 [TBL] [Abstract][Full Text] [Related]
14. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Shaib Y; Davila J; Naumann C; El-Serag H Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071 [TBL] [Abstract][Full Text] [Related]
15. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501 [TBL] [Abstract][Full Text] [Related]
16. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677 [TBL] [Abstract][Full Text] [Related]
17. Declining trends of epithelial ovarian cancer in California. Morris CR; Rodriguez AO; Epstein J; Cress RD Gynecol Oncol; 2008 Jan; 108(1):207-13. PubMed ID: 18028989 [TBL] [Abstract][Full Text] [Related]
18. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489 [TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer incidence in the United States, 1992-1999. Quirk JT; Natarajan N Gynecol Oncol; 2005 May; 97(2):519-23. PubMed ID: 15863154 [TBL] [Abstract][Full Text] [Related]
20. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Rosenberg J; Chia YL; Plevritis S Breast Cancer Res Treat; 2005 Jan; 89(1):47-54. PubMed ID: 15666196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]